A glutaminyl cyclase inhibitor
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

PBD-150

Item No. 36112

Technical Information
Formal Name
N-(3,4-dimethoxyphenyl)-N′-[3-(1H-imidazol-1-yl)propyl]-thiourea
CAS Number
790663-33-1
Molecular Formula
C15H20N4O2S
Formula Weight
Purity
≥98%
Formulation
A solid
DMF: 1 mg/mlDMSO: 1 mg/ml
λmax
249 nm
SMILES
S=C(NCCCN1C=NC=C1)NC2=CC(OC)=C(OC)C=C2
InChi Code
InChI=1S/C15H20N4O2S/c1-20-13-5-4-12(10-14(13)21-2)18-15(22)17-6-3-8-19-9-7-16-11-19/h4-5,7,9-11H,3,6,8H2,1-2H3,(H2,17,18,22)
InChi Key
FZQXMGLQANXZRP-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Product Description

    PBD-150 is an inhibitor of glutaminyl cyclase (Ki = 0.49 µM for the human enzyme).1 It inhibits the formation of the pyroglutamic acid-containing amyloid-β (Aβ) peptides pGlu-Aβ (3-40) and pGlu-Aβ (3-42) in HEK293 cells expressing human glutaminyl cyclase and human amyloid precursor protein (APP) with an N-terminal deletion of the first two amino acids.1

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Buchholz, M., Heiser, U., Schilling, S., et alThe first potent inhibitors for human glutaminyl cyclase: Synthesis and structure-activity relationship. J. Med. Chem. 49(2), 664-677 (2006).